BEHAVIORAL INDEXES OF BETA-RECEPTOR SUBSENSITIVITY AFTER CHRONIC TREATMENT WITH VILOXAZINE IN THE MOUSE

被引:1
|
作者
PORSOLT, RD [1 ]
LENEGRE, A [1 ]
MIGUEL, S [1 ]
LAVOISY, J [1 ]
机构
[1] ICI PHARMA FRANCE,F-95022 CERGY,FRANCE
关键词
Behavioral indices; Beta receptor subsensitivity; Beta-1; vs; beta-2; specificity; Chronic treatment; Imipramine; Viloxazine;
D O I
10.1016/0091-3057(90)90029-H
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The aim of the experiments was to determine whether chronic pretreatment with viloxazine decreased the sensitivity of mice to the sedative effects of a beta agonist clenbuterol. Mice were subjected to chronic oral treatment with viloxazine (128 mg/kg twice daily) and then given a single administration of 32 mg/kg PO followed by clenbuterol (0.125 mg/kg IP) before being tested in a standard photocell activity meter. Imipramine, administered at the same doses in the same experimental conditions, was used as a comparison compound. The results showed that chronic but not acute viloxazine decreased the hypoactivity induced by clenbuterol, suggesting the induction of beta receptor subsensitivity. With imipramine the results were in the same direction but less clear. The findings are discussed in terms of the eventual specificity of the viloxazine effect to subsensitivity in beta-2 receptors. © 1990.
引用
收藏
页码:567 / 570
页数:4
相关论文
共 50 条
  • [1] BETA-RECEPTOR RESPONSIVENESS AFTER DESIPRAMINE TREATMENT
    POHL, R
    PANDEY, GN
    YERAGANI, VK
    BALON, R
    DAVIS, JM
    BERCHOU, R
    PSYCHOPHARMACOLOGY, 1993, 110 (1-2) : 37 - 44
  • [2] Beta-receptor occupancy after chronic bisoprolol dosing.
    Rosebraugh, CJ
    Barbey, JT
    Funck-Brentano, C
    Yasuda, SU
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 150 - 150
  • [3] TREATMENT WITH BETA-RECEPTOR BLOCKERS
    EGIDY, HV
    INTERNIST, 1972, 13 (12): : 481 - 484
  • [4] TREATMENT WITH BETA-RECEPTOR BLOCKERS
    LYDTIN, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1969, 94 (49) : 2560 - &
  • [5] TREATMENT WITH BETA-RECEPTOR BLOCKERS
    RIECKER, G
    INTERNIST, 1992, 33 (09): : 618 - 621
  • [6] DISCONTINUATION PHENOMENA WITH BETA-RECEPTOR BLOCKERS AFTER THE END OF TREATMENT
    GILFRICH, HJ
    RAHN, KH
    MEDIZINISCHE WELT, 1981, 32 (26): : 1036 - 1037
  • [7] THE PLACE OF BETA-RECEPTOR BLOCKERS IN THE TREATMENT OF CHRONIC CARDIAC-FAILURE
    SCHWINGER, RHG
    BOHM, M
    ERDMANN, E
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 115 (21) : 825 - 831
  • [8] DOPAMINE RECEPTOR SUBSENSITIVITY IN THE SUBSTANTIA NIGRA AFTER CHRONIC MORPHINE TREATMENT IN RATS
    SPAMPINATO, U
    GOZLAN, H
    DAVAL, G
    FATTACCINI, CM
    HAMON, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 150 (1-2) : 113 - 122
  • [9] BEHAVIORAL EVIDENCE FOR DOPAMINE RECEPTOR SUBSENSITIVITY FOLLOWING CHRONIC HALOPERIDOL
    LYNCH, MR
    NEUROPSYCHOBIOLOGY, 1991, 24 (02) : 102 - 108
  • [10] BETA-RECEPTOR STIMULATION IN THE TREATMENT OF DEPRESSION
    SIMON, P
    LECRUBIER, Y
    JOUVENT, R
    PUECH, A
    WIDLOCHER, D
    ADVANCES IN BIOCHEMICAL PSYCHOPHARMACOLOGY, 1984, 39 : 293 - 299